Anixa Biosciences, Inc. (ANIX): Price and Financial Metrics
ANIX Price/Volume Stats
| Current price | $3.16 | 52-week high | $6.45 |
| Prev. close | $3.22 | 52-week low | $2.77 |
| Day low | $3.00 | Volume | 89,000 |
| Day high | $3.34 | Avg. volume | 78,763 |
| 50-day MA | $4.18 | Dividend yield | N/A |
| 200-day MA | $4.51 | Market Cap | 97.72M |
ANIX Stock Price Chart Interactive Chart >
Anixa Biosciences, Inc. (ANIX) Company Bio
Anixa Biosciences, Inc., a biotechnology company, develops diagnostics and therapeutics to diagnose, treat, and prevent cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of cancer, which is based on the body's immune response to the presence of a malignancy. It is also developing a vaccine against triple negative breast cancer; and chimeric endocrine receptor T-cell technology focused on treating ovarian cancer. Anixa Biosciences, Inc. has a collaboration with Urology San Antonio, P.A. and Idaho Urologic Institute, PA for the development of Cchek, a liquid biopsy technology; and with OntoChem GmbH to develop novel Covid-19 therapeutics. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
Latest ANIX News From Around the Web
Below are the latest news stories about ANIXA BIOSCIENCES INC that investors may wish to consider to help them evaluate ANIX as an investment opportunity.
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical TrialAnixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in conjunction with its partner Moffitt Cancer Center, it has commenced treatment of the second patient in the ongoing clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer. |
Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?Here is how ANIXA BIOSCIENCES INC (ANIX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year. |
Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study DataAnixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine. However, the stock plunges 25% in the absence of efficacy reports. |
Anixa Biosciences Clarifies Poster Presentation on Company WebsiteAnixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that a technical error was made by the company's website hosting service provider, causing a poster presentation unrelated to Anixa to be posted on the Corporate Presentations page of the company's website. The correct presentation of the company's breast cancer vaccine clinical trial from the 2023 AACR Annual Meeting may be found on the Events page of the company's w |
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer VaccineAnixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that Cleveland Clinic presented the most up-to-date data from the Phase 1 Trial of its breast cancer vaccine. The data presented showed that in the vaccinated women who have been tested to date, various levels of antigen-specific T cell responses were observed at all dose levels. The presentation was made by G. Thomas Budd, M.D., of Cleveland Clinic's Taussig Cancer I |
ANIX Price Returns
| 1-mo | -21.00% |
| 3-mo | -32.33% |
| 6-mo | -35.38% |
| 1-year | -11.98% |
| 3-year | 38.60% |
| 5-year | -14.36% |
| YTD | -25.65% |
| 2022 | 43.10% |
| 2021 | -3.26% |
| 2020 | -6.40% |
| 2019 | -16.75% |
| 2018 | 66.95% |
Continue Researching ANIX
Here are a few links from around the web to help you further your research on Anixa Biosciences Inc's stock as an investment opportunity:Anixa Biosciences Inc (ANIX) Stock Price | Nasdaq
Anixa Biosciences Inc (ANIX) Stock Quote, History and News - Yahoo Finance
Anixa Biosciences Inc (ANIX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...